SCHEMBL6175019

SCHEMBL6175019

CC(c1ccnc(C(=O)N2CCCCC2)c1)C1(C(C)c2ccnc(C(=O)N3CCCCC3)c2)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.37
DPP7 Q9UHL4 2/20 0.37
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TACR1 P25103 2/20 0.36
IGF1R P08069 2/20 0.35
SCN7A Q01118 1/20 0.34
KCNH2 Q12809 1/20 0.34
SCN9A Q15858 1/20 0.34
AR P10275 2/20 0.34
TRPV3 Q8NET8 2/20 0.33
CHRNA7 P36544 1/20 0.32
KMT2A Q03164 1/20 0.32
BTK Q06187 1/20 0.31
PREP P48147 1/20 0.31
SLC6A9 P48067 1/20 0.31
POLB P06746 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175941 0.92 PTGS2 (0.39) DPP4DPP7LMNAMAPK1HTT
SCHEMBL6175494 0.90 IGF1R (0.35) SMN1; SMN2TACR1IGF1RSCN7AKCNH2
SCHEMBL6173425 0.90 LMNA (0.38) LMNAMAPK1HTTSMN1; SMN2IGF1R
SCHEMBL6172914 0.88 IGF1R (0.38) LMNAHTTSMN1; SMN2IGF1RAR
SCHEMBL6173555 0.87 IGF1R (0.41) TACR1IGF1R
SCHEMBL6259895 0.85 LMNA (0.42) DPP4DPP7LMNAMAPK1HTT
SCHEMBL6173852 0.83 IGF1R (0.37) IGF1RARTRPV3CHRNA7KMT2A
SCHEMBL6172497 0.82 IGF1R (0.37) LMNASMN1; SMN2IGF1RARTRPV3
SCHEMBL6172419 0.81 HRH4 (0.38) LMNAMAPK1HTTSMN1; SMN2IGF1R
SCHEMBL6201343 0.81 PTGS2 (0.40) LMNAMAPK1HTTSMN1; SMN2IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed